Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial. - Maréchal, Céline; Lal, Himal; Heineman, Thomas C; Poder, Airi; Ferguson, Murdo; Enweonye, Igwebuike; Hervé, Caroline; Wauters, Dominique; Oostvogels, Lidia; Rheault, Paul; Talli, Jaak (Vaccine, 2018)